Sandra Chiu

952 total citations · 1 hit paper
35 papers, 479 citations indexed

About

Sandra Chiu is a scholar working on Infectious Diseases, Epidemiology and Molecular Biology. According to data from OpenAlex, Sandra Chiu has authored 35 papers receiving a total of 479 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Infectious Diseases, 15 papers in Epidemiology and 12 papers in Molecular Biology. Recurrent topics in Sandra Chiu's work include SARS-CoV-2 and COVID-19 Research (13 papers), Immunotherapy and Immune Responses (9 papers) and Herpesvirus Infections and Treatments (6 papers). Sandra Chiu is often cited by papers focused on SARS-CoV-2 and COVID-19 Research (13 papers), Immunotherapy and Immune Responses (9 papers) and Herpesvirus Infections and Treatments (6 papers). Sandra Chiu collaborates with scholars based in China, Poland and South Korea. Sandra Chiu's co-authors include Xia Chuai, Entao Li, Hwey‐Lian Hsieh, Horng‐Jyh Harn, Rui Gong, Tengchuan Jin, Shaohong Chen, Junhui Zhou, Weihong Zeng and Jinge Zhou and has published in prestigious journals such as Nature Communications, SHILAP Revista de lepidopterología and ACS Nano.

In The Last Decade

Sandra Chiu

28 papers receiving 475 citations

Hit Papers

Monkeypox virus: a re-emergent threat to humans 2022 2026 2023 2024 2022 50 100 150
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Monkeypox virus: a re-emergent threat to humans
    2022 166 citations Xia Chuai, Sandra Chiu et al. Virologica Sinica profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sandra Chiu China 11 267 224 180 117 69 35 479
Jörn Stitz Germany 16 393 1.5× 158 0.7× 100 0.6× 120 1.0× 67 1.0× 42 650
Г. В. Кочнева Russia 16 196 0.7× 126 0.6× 176 1.0× 83 0.7× 122 1.8× 75 609
Kazuhiro Matsuoka Japan 14 228 0.9× 150 0.7× 80 0.4× 189 1.6× 100 1.4× 28 483
Christine Ludwig Germany 10 342 1.3× 137 0.6× 77 0.4× 188 1.6× 98 1.4× 12 577
Shuai Cao China 14 215 0.8× 124 0.6× 224 1.2× 64 0.5× 141 2.0× 19 503
Wuxun Lu United States 15 490 1.8× 212 0.9× 404 2.2× 242 2.1× 198 2.9× 25 1.0k
G Rautmann France 11 435 1.6× 210 0.9× 125 0.7× 139 1.2× 117 1.7× 25 822
Gwen M. Taylor United States 13 180 0.7× 107 0.5× 155 0.9× 185 1.6× 162 2.3× 29 601
Aliaksandr Druz United States 17 460 1.7× 270 1.2× 287 1.6× 200 1.7× 167 2.4× 20 894
Sailaja Gangadhara United States 14 141 0.5× 341 1.5× 202 1.1× 113 1.0× 366 5.3× 25 601

Countries citing papers authored by Sandra Chiu

Since Specialization
Citations

This map shows the geographic impact of Sandra Chiu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sandra Chiu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sandra Chiu more than expected).

Fields of papers citing papers by Sandra Chiu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sandra Chiu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sandra Chiu. The network helps show where Sandra Chiu may publish in the future.

Co-authorship network of co-authors of Sandra Chiu

This figure shows the co-authorship network connecting the top 25 collaborators of Sandra Chiu. A scholar is included among the top collaborators of Sandra Chiu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sandra Chiu. Sandra Chiu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Ren, Yi, Pengfei Fan, Ting Fang, et al.. (2025). Potent Cross‐neutralizing Antibodies Reveal Vulnerabilities of Henipavirus Fusion Glycoprotein. Advanced Science. 12(27). e2501996–e2501996. 1 indexed citations
3.
Li, Entao, Qiyuan Yang, Wenyu Xie, et al.. (2025). An mpox quadrivalent mRNA vaccine elicits sustained and protective immunity in mice against lethal vaccinia virus challenge. Emerging Microbes & Infections. 14(1). 2447619–2447619. 2 indexed citations
4.
Li, Entao, Xiaoping Guo, Weiqi Wang, et al.. (2025). A single-chain mRNA vaccine co-expressing GPC and NP provides complete protection against lethal Dabie bandavirus challenge in mice. Molecular Therapy — Nucleic Acids. 36(4). 102755–102755.
5.
Li, Ming, Yao Zhong, Entao Li, et al.. (2024). An adenosine analog shows high antiviral potency against coronavirus and arenavirus mainly through an unusual base pairing mode. Nature Communications. 15(1). 10750–10750. 2 indexed citations
6.
Zhao, Yan, et al.. (2024). N6-Methyladenosine Positively Regulates Coxsackievirus B3 Replication. Viruses. 16(9). 1448–1448. 3 indexed citations
7.
Wu, Yi, Xiaoying Jia, Xinghai Zhang, et al.. (2024). Boosting with Omicron-specific mRNA vaccine or historical SARS-CoV-2 vaccines elicits discriminating immune responses against Omicron variants. Acta Pharmaceutica Sinica B. 15(2). 947–962.
8.
Chen, Shaohong, Xinghai Zhang, Yanfeng Yao, et al.. (2024). Ferritin nanoparticle-based Nipah virus glycoprotein vaccines elicit potent protective immune responses in mice and hamsters. Virologica Sinica. 39(6). 909–916. 5 indexed citations
9.
Zhang, Huajun, Yanfeng Yao, Ming Li, et al.. (2024). Potent human neutralizing antibodies against Nipah virus derived from two ancestral antibody heavy chains. Nature Communications. 15(1). 2987–2987. 13 indexed citations
10.
Chuai, Xia, Baoxin Zhao, Yan Wu, et al.. (2024). Long‐Lasting Protection and Dose Optimization of MPXV Polyvalent Mpox mRNA Vaccines Against Lethal Vaccinia Virus Challenge in Mice. Journal of Medical Virology. 97(1). e70143–e70143. 3 indexed citations
11.
Zhou, Jinge, Kaiyue Zhang, Yuping Wang, et al.. (2024). Polyvalent mpox mRNA vaccines elicit robust immune responses and confer potent protection against vaccinia virus. Cell Reports. 43(6). 114269–114269. 20 indexed citations
12.
Zhou, Jinge, Yun Yang, Entao Li, et al.. (2024). Circular RNA vaccines against monkeypox virus provide potent protection against vaccinia virus infection in mice. Molecular Therapy. 32(6). 1779–1789. 37 indexed citations
13.
Wang, Shen, Wanying Yang, Entao Li, et al.. (2024). Emerging and reemerging infectious diseases: global trends and new strategies for their prevention and control. Signal Transduction and Targeted Therapy. 9(1). 223–223. 22 indexed citations
14.
Li, Entao, Xiaoping Guo, Wenyu Xie, et al.. (2023). Duration of humoral immunity from smallpox vaccination and its cross-reaction with Mpox virus. Signal Transduction and Targeted Therapy. 8(1). 350–350. 27 indexed citations
15.
Zeng, Weihong, Xiaoying Jia, Xiangyang Chi, et al.. (2023). An engineered bispecific nanobody in tetrameric secretory IgA format confers broad neutralization against SARS-CoV-1&2 and most variants. International Journal of Biological Macromolecules. 253(Pt 3). 126817–126817. 7 indexed citations
16.
Wu, Yi, Xiaoying Jia, Yan Wu, et al.. (2023). Long‐term immune response to Omicron‐specific mRNA vaccination in mice, hamsters, and nonhuman primates. SHILAP Revista de lepidopterología. 4(6). e460–e460. 5 indexed citations
17.
Ma, Huan, Xinghai Zhang, Peter H. Dube, et al.. (2022). Hetero-bivalent nanobodies provide broad-spectrum protection against SARS-CoV-2 variants of concern including Omicron. Cell Research. 32(9). 831–842. 26 indexed citations
18.
Zhang, Xinghai, Huajun Zhang, Tingting Li, et al.. (2022). A potent neutralizing antibody provides protection against SARS-CoV-2 Omicron and Delta variants via nasal delivery. Signal Transduction and Targeted Therapy. 7(1). 301–301. 10 indexed citations
19.
20.
Chuai, Xia, et al.. (2022). Monkeypox virus: a re-emergent threat to humans. Virologica Sinica. 37(4). 477–482. 166 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jörn Stitz Breakdown of academic impact, for papers by Г. В. Кочнева Breakdown of academic impact, for papers by Kazuhiro Matsuoka Breakdown of academic impact, for papers by Christine Ludwig Breakdown of academic impact, for papers by Shuai Cao Breakdown of academic impact, for papers by Wuxun Lu Breakdown of academic impact, for papers by G Rautmann Breakdown of academic impact, for papers by Gwen M. Taylor Breakdown of academic impact, for papers by Aliaksandr Druz Breakdown of academic impact, for papers by Sailaja Gangadhara
Rankless by CCL
2026